The Indiana-based drugmaker is slashing the prices of its 2.5 mg single-dose vials to $349 per month and bringing its 5 mg single-dose vials down to $499 per month, it said in a Tuesday press release.
and a 130mg/26mL single-dose vial for intravenous (IV) infusion. According to Sandoz, the product has extended stability and can be re-refrigerated, unlike the reference medicine. Selarsdi is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback